Provider-supervised medical weight loss in Lincoln, NE, using semaglutide, tirzepatide, comprehensive lab work, nutrition guidance, and ongoing clinical oversight when appropriate.
Clinical information from Revi's provider-led care team · Updated September 29, 2026
Not sure where to start? Take the 60-second fit quiz — it matches your symptoms to the right therapy.
You do not need to know whether semaglutide, tirzepatide, hormone support, or nutrition changes are the right fit yet. Revi starts with labs, then builds the plan around what your body is actually showing.
Take the fit quiz and get pointed toward the best starting conversation.
The right plan depends on hormones, thyroid, metabolism, and what your body is actually showing.
Revi pairs medical weight loss with body-composition and nutrition perspective.
Stubborn weight rarely responds to willpower alone, especially in your late 30s, 40s, and 50s. The hormonal, metabolic, and signaling shifts that accumulate with age change how your body responds to the same inputs. Medical weight loss therapy can help — when it's used as part of a comprehensive plan, not as a shortcut.
At Revi, semaglutide and tirzepatide are part of the toolkit when clinically indicated. They are not the whole answer. We use them under provider supervision, alongside lab-based assessment of the underlying drivers (thyroid, hormones, metabolic function, inflammation) and an in-house nutrition perspective most weight loss clinics don't have.
Semaglutide is a GLP-1 receptor agonist medication. It is the active ingredient in Wegovy and Ozempic and is used to support appetite regulation, satiety, and metabolic function as part of a comprehensive medical weight loss plan.
At Revi, semaglutide is not treated as a shortcut or a standalone answer. We pair medication review with labs, nutrition strategy, side effect monitoring, and a plan for what happens as weight changes. Learn more about Semaglutide →
Tirzepatide is a dual GIP/GLP-1 receptor agonist. It is the active ingredient in Mounjaro and Zepbound. It acts on two metabolic pathways and may support appetite regulation, insulin response, and weight loss outcomes when clinically appropriate.
Your provider helps determine whether semaglutide, tirzepatide, or a different approach best fits your labs, health history, goals, and risk profile. Learn more about Tirzepatide →
FDA-approved Wegovy and Zepbound have been reviewed for safety, effectiveness, and quality. Compounded GLP-1 drugs are not FDA approved and may be used only in limited circumstances permitted by federal law. If a compounded option is considered, the clinical team explains why, the current regulatory status, and how it differs from an FDA-approved product.
Patterns we commonly see in patients who benefit from medical weight loss therapy:
We're not the right clinic if you're looking for a 15-minute video call and a prescription with no labs. Several reputable national chains operate that way. We work differently because the underlying drivers of stubborn weight are individual, and the right treatment depends on what your labs actually show.
The same process for every medical weight loss patient at Revi.
1. Comprehensive labs before your first visit. Hormone panel, thyroid, metabolic markers (insulin, glucose, HbA1c, lipids), inflammation indicators. Your consultation begins with real data.
2. Medical review with the clinical team. Your labs, weight history, metabolic markers, medical history, and goals are reviewed together. The clinical team determines whether GLP-1 therapy is appropriate and what supporting therapies may be useful.
3. Personalized treatment plan. GLP-1 selection (semaglutide or tirzepatide), dose, escalation schedule, and supporting interventions (hormone therapy, peptide support for body composition, nutrition guidance) are matched to your individual case.
4. Ongoing monitoring. Regular check-ins, follow-up labs, dose adjustments, side effect management, and integration with the broader physiological picture. Your protocol evolves as your body responds.
"Medications can change the playing field. They can't replace the fundamentals — protein intake, resistance training, sleep, and consistency. The clients who do best on GLP-1 therapies are the ones who use the appetite-regulating window to build sustainable habits, not the ones who treat the medication as the whole answer." — Steve Lucchino, Cofounder, Revi 18+ years in nutrition and supplement industry. Macro-based nutrition coach to 100+ clients. Read full bio →
Nutrition, adequate protein, resistance training, sleep, and a follow-up plan help protect health and function during weight loss. Medication remains one part of coordinated care.
We discuss the specifics during your consultation. FDA-approved branded options are reviewed first. If a compounded option is discussed, your provider will explain the current regulatory status, whether it is legally and clinically appropriate for your case, and how availability affects the plan.
Initial appetite changes often start within the first week. Meaningful weight loss typically begins within the first month and continues over 6-12 months as the dose is titrated to your response. Your provider sets specific expectations based on your starting point and goals.
GLP-1 medications can cause nausea, gastrointestinal symptoms, constipation, and reduced appetite, especially during dose escalation. Most side effects are dose-related and improve with adjustment. Less common but more serious side effects (pancreatitis, gallbladder issues, thyroid concerns in patients with personal/family history of medullary thyroid carcinoma) are reviewed during your consultation. Tell your provider about any history of pancreatitis, gallbladder disease, or relevant family history.
Highly individual. Duration is individualized. Obesity is commonly managed as a chronic condition, and stopping medication can lead to weight regain. Your provider periodically reviews benefits, risks, response, access, and whether continued treatment remains appropriate.
Without continued lifestyle support, weight regain is common after stopping GLP-1 therapy. The medication shifts appetite and metabolic regulation while you take it; when you stop, those signals return to baseline. Sustainable results depend on building habits during the medication window — which is part of why we build nutrition support into our medical weight loss plans.
Sometimes. Each treatment needs its own clinical indication, risk review, and monitoring plan. Your provider evaluates whether either or both are appropriate.
Because the underlying drivers of stubborn weight (thyroid, insulin resistance, hormonal shifts, inflammation) are individual, and the right treatment depends on what your labs actually show. Skipping labs means skipping the diagnostic step that distinguishes "GLP-1 is the right tool" from "GLP-1 is part of a bigger plan."
Costs vary by medication, dose, pharmacy, labs, and follow-up needs. We discuss pricing during your consultation before treatment begins.
Then we don't recommend it. Some patients have contraindications; others respond better to hormone optimization, metabolic support, or other approaches. Your labs and history guide the conversation; not every patient leaves with a GLP-1 prescription.
Owner and Medical Director. Board-certified interventional radiologist with 20+ years of experience.
Read full bio →